Literature DB >> 20166152

No evidence for clonal selection due to lentiviral integration sites in human induced pluripotent stem cells.

Thomas Winkler1, Amy Cantilena, Jean-Yves Métais, Xiuli Xu, Anh-Dao Nguyen, Bhavesh Borate, Jessica E Antosiewicz-Bourget, Tyra G Wolfsberg, James A Thomson, Cynthia E Dunbar.   

Abstract

Derivation of induced pluripotent stem (iPS) cells requires the expression of defined transcription factors (among Oct3/4, Sox2, Klf4, c-Myc, Nanog, and Lin28) in the targeted cells. Lentiviral or standard retroviral gene transfer remains the most robust and commonly used approach. Low reprogramming frequency overall, and the higher efficiency of derivation utilizing integrating vectors compared to more recent nonviral approaches, suggests that gene activation or disruption via proviral integration sites (IS) may play a role in obtaining the pluripotent phenotype. We provide for the first time an extensive analysis of the lentiviral integration profile in human iPS cells. We identified a total of 78 independent IS in eight recently established iPS cell lines derived from either human fetal fibroblasts or newborn foreskin fibroblasts after lentiviral gene transfer of Oct4, Sox2, Nanog, and Lin28. The number of IS ranged from 5 to 15 IS per individual iPS clone, and 75 IS could be assigned to a unique chromosomal location. The different iPS clones had no IS in common. Expression analysis as well as extensive bioinformatic analysis did not reveal functional concordance of the lentiviral targeted genes between the different clones. Interestingly, in six of the eight iPS clones, some of the IS were found in pairs, integrated into the same chromosomal location within six base pairs of each other or in very close proximity. Our study supports recent reports that efficient reprogramming of human somatic cells is not dependent on insertional activation or deactivation of specific genes or gene classes.

Entities:  

Mesh:

Year:  2010        PMID: 20166152      PMCID: PMC3173982          DOI: 10.1002/stem.322

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  46 in total

1.  Murine leukemia induced by retroviral gene marking.

Authors:  Zhixiong Li; Jochen Düllmann; Bernd Schiedlmeier; Manfred Schmidt; Christof von Kalle; Johann Meyer; Martin Forster; Carol Stocking; Anke Wahlers; Oliver Frank; Wolfram Ostertag; Klaus Kühlcke; Hans-Georg Eckert; Boris Fehse; Christopher Baum
Journal:  Science       Date:  2002-04-19       Impact factor: 47.728

Review 2.  Genome-wide analysis of retroviral DNA integration.

Authors:  Frederic Bushman; Mary Lewinski; Angela Ciuffi; Stephen Barr; Jeremy Leipzig; Sridhar Hannenhalli; Christian Hoffmann
Journal:  Nat Rev Microbiol       Date:  2005-11       Impact factor: 60.633

3.  Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking.

Authors:  Olga Kustikova; Boris Fehse; Ute Modlich; Min Yang; Jochen Düllmann; Kenji Kamino; Nils von Neuhoff; Brigitte Schlegelberger; Zhixiong Li; Christopher Baum
Journal:  Science       Date:  2005-05-20       Impact factor: 47.728

4.  Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells.

Authors:  Boris Calmels; Cole Ferguson; Mikko O Laukkanen; Rima Adler; Marion Faulhaber; Hyeoung-Joon Kim; Stephanie Sellers; Peiman Hematti; Manfred Schmidt; Christof von Kalle; Keiko Akagi; Robert E Donahue; Cynthia E Dunbar
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

5.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

Authors:  Marion G Ott; Manfred Schmidt; Kerstin Schwarzwaelder; Stefan Stein; Ulrich Siler; Ulrike Koehl; Hanno Glimm; Klaus Kühlcke; Andrea Schilz; Hana Kunkel; Sonja Naundorf; Andrea Brinkmann; Annette Deichmann; Marlene Fischer; Claudia Ball; Ingo Pilz; Cynthia Dunbar; Yang Du; Nancy A Jenkins; Neal G Copeland; Ursula Lüthi; Moustapha Hassan; Adrian J Thrasher; Dieter Hoelzer; Christof von Kalle; Reinhard Seger; Manuel Grez
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

6.  LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Authors:  S Hacein-Bey-Abina; C Von Kalle; M Schmidt; M P McCormack; N Wulffraat; P Leboulch; A Lim; C S Osborne; R Pawliuk; E Morillon; R Sorensen; A Forster; P Fraser; J I Cohen; G de Saint Basile; I Alexander; U Wintergerst; T Frebourg; A Aurias; D Stoppa-Lyonnet; S Romana; I Radford-Weiss; F Gross; F Valensi; E Delabesse; E Macintyre; F Sigaux; J Soulier; L E Leiva; M Wissler; C Prinz; T H Rabbitts; F Le Deist; A Fischer; M Cavazzana-Calvo
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

7.  Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.

Authors:  Zhaohui Ye; Huichun Zhan; Prashant Mali; Sarah Dowey; Donna M Williams; Yoon-Young Jang; Chi V Dang; Jerry L Spivak; Alison R Moliterno; Linzhao Cheng
Journal:  Blood       Date:  2009-10-01       Impact factor: 22.113

8.  High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors.

Authors:  Yue Ma; Ali Ramezani; Rachel Lewis; Robert G Hawley; James A Thomson
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

9.  Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells.

Authors:  Peiman Hematti; Bum-Kee Hong; Cole Ferguson; Rima Adler; Hideki Hanawa; Stephanie Sellers; Ingeborg E Holt; Craig E Eckfeldt; Yugal Sharma; Manfred Schmidt; Christof von Kalle; Derek A Persons; Eric M Billings; Catherine M Verfaillie; Arthur W Nienhuis; Tyra G Wolfsberg; Cynthia E Dunbar; Boris Calmels
Journal:  PLoS Biol       Date:  2004-11-23       Impact factor: 8.029

10.  Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences.

Authors:  Rick S Mitchell; Brett F Beitzel; Astrid R W Schroder; Paul Shinn; Huaming Chen; Charles C Berry; Joseph R Ecker; Frederic D Bushman
Journal:  PLoS Biol       Date:  2004-08-17       Impact factor: 8.029

View more
  18 in total

Review 1.  Induced pluripotency: history, mechanisms, and applications.

Authors:  Matthias Stadtfeld; Konrad Hochedlinger
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

Review 2.  Progress in understanding reprogramming to the induced pluripotent state.

Authors:  Kathrin Plath; William E Lowry
Journal:  Nat Rev Genet       Date:  2011-04       Impact factor: 53.242

3.  iPSCs: Unstable origins?

Authors:  Sayandip Mukherjee; Adrian J Thrasher
Journal:  Mol Ther       Date:  2011-07       Impact factor: 11.454

Review 4.  Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells.

Authors:  So Gun Hong; Cynthia E Dunbar; Thomas Winkler
Journal:  Mol Ther       Date:  2012-12-04       Impact factor: 11.454

5.  Simple derivation of transgene-free iPS cells by a dual recombinase approach.

Authors:  Anna Pertek; Florian Meier; Martin Irmler; Johannes Beckers; Stavroula Skylaki; Max Endele; Wolfgang Wurst; Nilima Prakash; Ralf Kühn
Journal:  Mol Biotechnol       Date:  2014-08       Impact factor: 2.695

6.  High-efficiency transduction of rhesus hematopoietic repopulating cells by a modified HIV1-based lentiviral vector.

Authors:  Naoya Uchida; Phillip W Hargrove; Coen J Lap; Molly E Evans; Oswald Phang; Aylin C Bonifacino; Allen E Krouse; Mark E Metzger; Anh-Dao Nguyen; Matthew M Hsieh; Tyra G Wolfsberg; Robert E Donahue; Derek A Persons; John F Tisdale
Journal:  Mol Ther       Date:  2012-08-07       Impact factor: 11.454

Review 7.  Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.

Authors:  Chuanfeng Wu; Cynthia E Dunbar
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

8.  Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systems.

Authors:  Sheng Zhou; Melissa A Bonner; Yong-Dong Wang; Samuel Rapp; Suk See De Ravin; Harry L Malech; Brian P Sorrentino
Journal:  Hum Gene Ther Methods       Date:  2015-02-05       Impact factor: 2.396

9.  Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells.

Authors:  Johannes Kuehle; Soeren Turan; Tobias Cantz; Dirk Hoffmann; Julia D Suerth; Tobias Maetzig; Daniela Zychlinski; Christoph Klein; Doris Steinemann; Christopher Baum; Juergen Bode; Axel Schambach
Journal:  Mol Ther       Date:  2014-01-17       Impact factor: 11.454

10.  Significant differences in genotoxicity induced by retrovirus integration in human T cells and induced pluripotent stem cells.

Authors:  Weiyan Zheng; Yingjia Wang; Tammy Chang; He Huang; Jiing-Kuan Yee
Journal:  Gene       Date:  2013-01-31       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.